American Journal of Kidney Diseases
Volume 55, Issue 5 , Pages 820-823 , May 2010

First Identification of an Antigen in Autoimmune Idiopathic Membranous Nephropathy: Toward Targeted Therapy?

  • Pierre Ronco, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Pierre Ronco, MD, PhD, Service de Néphrologie et Dialyses, Hôpital Tenon, 4 rue de la Chine, F-75020, Paris, France
    • ,
  • Hanna Debiec, PhD

References 

  1. Wasserstein AG. Membranous glomerulonephritis. J Am Soc Nephrol. 1997;8(4):664–674
  2. Glassock RJ. Diagnosis and natural course of MN. Semin Nephrol. 2003;23(4):324–332
  3. Imai H, Hamai K, Komatsuda A, Ohtani H, Miura AB. IgG subclasses in patients with membranoproliferative glomerulonephritis, MN, and lupus nephritis. Kidney Int. 1997;51(1):270–276
  4. Kuroki A, Shibata T, Honda H, Totsuka D, Kobayashi K, Sugisaki T. Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Int Med. 2002;41(11):936–942
  5. Glassock RJ. The treatment of idiopathic membranous nephropathy: a dilemma or a conundrum?. Am J Kidney Dis. 2004;44(3):562–566
  6. Perna A, Schieppati A, Zamora J, et al. Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review. Am J Kidney Dis. 2004;44(3):385–401
  7. Ruggenenti P, Chiurchiu C, Brusegan V, et al. Rituximab in idiopathic membranous nephropathy: a one-year prospective study. J Am Soc Nephrol. 2003;14(7):1851–1857
  8. Cunningham PN, Quigg RJ. Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol. 2005;16(5):1214–1222
  9. Heymann W, Hackel DB, Harwood S, Wilson SGF, Hunter JL. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspension. Proc Soc Exp Biol Med. 1959;100(4):660–664
  10. Kerjaschki D, Farquhar MG. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A. 1982;79(18):5557–5561
  11. Kerjaschki D, Farquhar MG. Immunocytochemical localization of the Heymann nephritis antigen (gp330) in glomerular epithelial cells of normal Lewis rats. J Exp Med. 1983;157(2):667–686
  12. Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med. 2002;346(26):2053–2060
  13. Debiec H, Nauta J, Coulet F, et al. Role of truncating mutations in MME gene in fetomaternal alloimmunization and antenatal glomerulopathies. Lancet. 2004;364(9441):1252–1259
  14. Beck LH, Bonegio RG, Lambeau G, et al. M-Type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21
  15. Hellmark T, Burkhardt H, Wieslander J. Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies. J Biol Chem. 1999;274(36):25862–25868
  16. Hudson BG. The molecular basis of Goodpasture and Alport syndromes: beacons for the discovery of the collagen IV family. J Am Soc Nephrol. 2004;15(10):2514–2527
  17. Kain R, Exner M, Brandes R, et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med. 2008;14(10):1088–1096
  18. Shah P, Tramontano A, Makker SP. Intramolecular epitope spreading in Heymann nephritis. J Am Soc Nephrol. 2007;18(12):3060–3066
  19. Lundberg K, Venables PJ. Epitope spreading in animal models: array of hope in rheumatoid arthritis and multiple sclerosis. Arthritis Res Ther. 2008;10(6):122–123
  20. Chen L, Hellmark T, Pedchenko V, et al. A nephritogenic peptide induces intermolecular epitope spreading on collagen IV in experimental autoimmune glomerulonephritis. J Am Soc Nephrol. 2006;17(11):3076–3081
  21. Zanetti M, Druet P. Passive Heymann's nephritis as a model of immune glomerulonephritis mediated by antibodies to immunoglobulins. Clin Exp Immunol. 1980;41(2):189–195
  22. Hennig C, Rink L, Kirchner H. Evidence for presence of IgG4 anti-immunoglobulin autoantibodies in all human beings. Lancet. 2000;355(9215):1617–1618
  23. Aalberse RC, Schuurman J. IgG4 breaking the rules. Immunology. 2002;105:9–19
  24. Penny MJ, Boyd RA, Hall BM. Permanent CD8(+) T cell depletion prevents proteinuria in active Heymann nephritis. J Exp Med. 1998;188(10):1775–1784
  25. Reynolds J, Prodromidi EI, Juggapah JK, et al. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. J Am Soc Nephrol. 2005;16(5):1350–1359
  26. Reynolds J, Abbott DS, Karegli J, Evans DJ, Pusey CD. Mucosal tolerance induced by an immunodominant peptide from rat alpha3(IV)NC1 in established experimental autoimmune glomerulonephritis. Am J Pathol. 2009;174(6):2202–2210

 Originally published online as doi:10.1053/j.ajkd.2009.09.017 on November 18, 2009.

PII: S0272-6386(09)01267-0

doi: 10.1053/j.ajkd.2009.09.017

American Journal of Kidney Diseases
Volume 55, Issue 5 , Pages 820-823 , May 2010

Article Tools

* Image Usage & Resolution